Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats

This program provides funding to a broad range of entities involved in health research and innovation, focusing on addressing global health threats. It supports the scientific and clinical communities, including various healthcare stakeholders, and has specific provisions for participation from the United States.

This funding initiative targets projects focused on developing and advancing in vitro diagnostic devices and related technologies. It covers various stages of innovation, from early studies to market readiness, across critical health sectors, emphasizing a holistic 'One Health' approach.

The program provides financial support in the form of grants, with a significant maximum funding amount per project aimed at fostering impactful innovation in health diagnostics.

Applicants must adhere to specific conditions related to application submission, project implementation, and collaboration. Key requirements include detailed regulatory compliance, ethical considerations, and engagement with relevant stakeholders.

The application process for this program follows a single-stage submission, with evaluation based on defined criteria and timelines, managed through the Funding & Tenders Portal.

This funding program operates under a robust legal framework established by key European Union regulations and specific Horizon Europe legislative acts, ensuring its legitimacy and guiding its operational principles.